Cross-Reactivity, Epitope Spreading, and De Novo Immune Stimulation Are Possible Mechanisms of Cross-Protection of Nonvaccine Human Papillomavirus (HPV) …
M Nakagawa, W Greenfield… - Clinical and Vaccine …, 2015 - Am Soc Microbiol
Numerous versions of human papillomavirus (HPV) therapeutic vaccines designed to treat
individuals with established HPV infection, including those with cervical intraepithelial …
individuals with established HPV infection, including those with cervical intraepithelial …
Pathogenesis of infection by human papillomavirus
SA Brendle, SM Bywaters, ND Christensen - Human Papillomavirus, 2014 - karger.com
Human papillomaviruses (HPVs) are associated with benign lesions known as warts and
several cancer types including cancer of the cervix, penis, anus and oral cavity. HPVs are …
several cancer types including cancer of the cervix, penis, anus and oral cavity. HPVs are …
Impact and cost-effectiveness of different vaccination strategies to reduce the burden of pneumococcal disease among elderly in the Netherlands
D Thorrington, L Van Rossum, M Knol, H De Melker… - PLoS …, 2018 - journals.plos.org
Background Streptococcus pneumoniae causes morbidity and mortality among all ages in
The Netherlands. To reduce this burden, infants in The Netherlands receive the 10-valent …
The Netherlands. To reduce this burden, infants in The Netherlands receive the 10-valent …
Comparative cost-effectiveness of the quadrivalent and bivalent human papillomavirus vaccines: a transmission-dynamic modeling study
Background The quadrivalent and bivalent human papillomavirus (HPV) vaccines are now
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
licensed in several countries. We compared the cost-effectiveness of the HPV vaccines to …
Public health impact and cost-effectiveness of switching from bivalent to nonavalent vaccine for human papillomavirus in Norway: incorporating the full health impact …
I Diakite, S Nguyen, U Sabale, A Pavelyev… - Journal of Medical …, 2023 - Taylor & Francis
Aim The objective of this study was to estimate and compare the cost-effectiveness of
switching from a bivalent to a nonavalent human papillomavirus (HPV) vaccination program …
switching from a bivalent to a nonavalent human papillomavirus (HPV) vaccination program …
[HTML][HTML] Cost-effectiveness analysis of a gender-neutral human papillomavirus vaccination program in the Netherlands
JJM Simons, N Vida, TA Westra, MJ Postma - Vaccine, 2020 - Elsevier
Background Vaccinating girls against human papillomavirus (HPV) infection is a highly
effective and cost-effective intervention to provide protection against HPV-induced cancers …
effective and cost-effective intervention to provide protection against HPV-induced cancers …
Cost-effectiveness of bivalent, quadrivalent, and nonavalent HPV vaccination in South Africa
DT Michaeli, S Stoycheva, SM Marcus, W Zhang… - Clinical Drug …, 2022 - Springer
Abstract Background and Objectives In South Africa, the prevalence of human
papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is …
papillomavirus (HPV) and associated diseases, such as cervical cancer and genital warts, is …
[图书][B] Viral nanotechnology
Y Khudyakov, P Pumpens - 2015 - books.google.com
This book presents a review of a rapidly developing field of viral nanotechnology in the
context of immunology, virology, microbiology, chemistry, physics, and mathematical …
context of immunology, virology, microbiology, chemistry, physics, and mathematical …
[HTML][HTML] Cost-utility analysis of human papillomavirus vaccination and cervical screening on cervical cancer patient in Indonesia
D Setiawan, FC Dolk, AA Suwantika, TA Westra… - Value in Health …, 2016 - Elsevier
Background Although cervical cancer is a preventable disease, the clinical and economic
burdens of cervical cancer are still substantial issues in Indonesia. Objectives The main …
burdens of cervical cancer are still substantial issues in Indonesia. Objectives The main …
Health and economic impact of a tender-based, sex-neutral human papillomavirus 16/18 vaccination program in the Netherlands
V Qendri, JA Bogaards, J Berkhof - The Journal of infectious …, 2017 - academic.oup.com
Background Uptake of human papillomavirus (HPV) vaccine among girls in the Dutch
immunization program has plateaued at around 60%. Vaccinating boys may be an …
immunization program has plateaued at around 60%. Vaccinating boys may be an …